Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
|
Maire-Claude Battista
Director
Université de Sherbrooke
|
Veronique Bougie
Chief Operating Officer
SemaThera Inc.
|
Susan Chapelle
Chief Operating Officer
PurMinds NeuroPharma
|
Marie-Eve Charrois
VP, Regulatory Affairs
IMV Inc.
|
Nadia Di Chiara
Portfolio Manager
Fonds de solidarité FTQ
|
Marie Di Maso
Executive Director
Corealis Pharma
|
Veronique Dugas
Vice-President Scientific Affairs
CQDM
|
Fiona Fitzgerald
Zone Leader, Canada
Cytiva
|
Allison Hagerman
VP, Product Development
Oncolytics Biotech Inc.
|
Nathalie Hebert
General Manager
Charles River Labs
|
Petra Hillebrand
Consultant
|
Melanie Kelly
Chief Scientific Officer
TetraBio-Pharma Inc.
|
Karine Lalonde
Vice President
Inversago
|
Marie-Christine Locas
Senior Director
Medicago
|
Terri Lohnes
Founder
Tekama Advisory
|
Aidan McNeil
Associate General Counsel & VP Administration
LQT Therapeutics, Inc.
|
Christine Mormont
Director, Medical Affairs
Novocure
|
Gilly Regev
CEO
SaNOtize
|
Marie-Helene Reid
Director of Operations
Charles River Labs
|
Nawel Rojkjaer
Founder & President
SmokePond Biologics
|
Elsa Rolo
Consultant
Human Capital Management
E.R. Inc.
|
Julia Schoelermann
VP Business Development
35 Pharma
|
Louise St Onge
Head, Pricing, Market Access, & Government Affairs
Mitsubishi Tanabe Pharma Canada
|
Kristin Tweel
Director, Sector Innovation
Genome Atlantic
|
Jolanda Westerlaken
Head of Global Regulatory Affairs CMC & Devices
UCB
|
Lindsay Williams
VP, Managing Director
Stryker Canada
Thank you to our program sponsors
|
|
|
|
|
|